P-selectin and PSGL-1: Exploiting connections between inflammation and venous thrombosis

Thrombosis and Haemostasis

Volumn 87, Issue 3, 2002, Pages 364-365

  McEver, Rodger P ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PENTASACCHARIDE; RECOMBINANT P SELECTIN GLYCOPROTEIN LIGAND 1 ANTIBODY; SELECTIN ANTAGONIST; THROMBIN INHIBITOR; UNCLASSIFIED DRUG; LIGAND; MEMBRANE PROTEIN; P SELECTIN LIGAND PROTEIN; P-SELECTIN LIGAND PROTEIN;

ANTIINFLAMMATORY ACTIVITY; BLEEDING DISORDER; BLOOD CLOT LYSIS; CLINICAL TRIAL; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHESION DEFICIENCY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOEMBOLISM; VEIN THROMBOSIS; ANIMAL; DRUG EFFECT; GENETICS; IMMUNOLOGY; NEUTROPHIL CHEMOTAXIS; PROTEIN ENGINEERING;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; HUMANS; INFLAMMATION; LIGANDS; MEMBRANE GLYCOPROTEINS; P-SELECTIN; PROTEIN ENGINEERING; VENOUS THROMBOSIS;

EID: 0036119781     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613012     Document Type: Note

References (27)

1. Role of coagulation inhibitors in inflammation
2. Inflammation and thrombosis: The clot thickens
3. New and effective treatment of experimentally induced venous thrombosis with anti-inflammatory rPSGL-Ig
4. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation
5. Platelets, leukocytes, and coagulation
6. Role of PSGL-1 binding to selectins in leukocyte recruitment
7. A novel glycosulfopeptide binds to P-selectin and inhibits leukocyte adhesion to P-selectin
8. Binding of glycosulfopeptides to P-selectin requires stereospecific contributions of individual tyrosine sulfate and sugar residues
9. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1
10. Dimerization of a selectin and its ligand stabilizes cell rolling and enhances tether strength in shear flow
11. P-selectin must extend a sufficient length from the plasma membrane to mediate rolling of neutrophils
12. Interactions of the cytoplasmic domain of P-selectin with clathrin-coated pits enhance leukocyte adhesion under flow
13. Direct observation of membrane tethers formed during neutrophil attachment to platelets or P-selectin under physiological flow
14. Adhesion and signaling in vascular cell-cell interactions
15. Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis
16. Blood-borne tissue factor: Another view of thrombosis
17. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor
18. Procoagulant state resulting from high levels of soluble P-selectin in blood
19. Pretreatment with a blocking monoclonal antibody to P-selectin accelerates pharmacological thrombolysis in a primate model of arterial thrombosis
20. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model
21. P-selectin and TNF inhibition reduce venous thrombosis inflammation
22. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis
23. P-selectin-dependent inhibition of thrombosis during venous stasis
24. P-selectin antagonism causes dose-dependent venous thrombosis inhibition
25. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis
26. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis
27. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials